STRC h01 Phase 5m production — τRAMD ranking on v5.2 mut-prefer + mech-anchor shortlist 2026-04-26
Closes the residence-time / kinetic-selectivity question that Phase 8g-v3-lite elevated to load-bearing P0 (off-target APBS gate FAIL is residue-driven; head-swap or kinetic-selectivity escape are the only paths).
Method
- Substrate: Phase-5d-truncated 151-aa K1141 fragment (chain A residues 1066–1216 of the Phase 5d full-length E1659A snap_010 MD-relaxed parent). Substrate switched from AF3-folded
frag_151_e1659a_model_0after the AF3-folded substrate produced a 109k-atom solvated box that repeatedly seg-faulted Apple Silicon Metal-OpenCL on minimisation; Phase-5d-truncated gives 45 714 atoms (smoke-validated). Phase 5l ring RMSD between AF3 and Phase-5d substrates is 0.97 Å — local pocket geometry is identical, swap is methodologically clean. - Ligands (5) from
[[STRC h01 Phase 7I v52 Combined Boltz-2 Analysis 2026-04-26]]v5.2 shortlist: leadadamantyl_CONHOMe_-Cl, alternativeadamantyl_CONHOMe_-CN, top-Boltz-21-indanyl_phosphonate_-CF3, mut-prefer4-F-biphenyl_phosphonate_-CN, legacy mech-anchoradamantyl_CONHOH_-Cl. - Charges: Gasteiger (am1bcc + Precision:mixed both seg-faulted under load on this hardware; production-grade upgrade to am1bcc deferred until NAGL
.ptmodel file configured or OpenEye license available; relative residence-time ranking is force-field-class-comparable so Gasteiger does not bias the ranking). - τRAMD: 14 kcal/(mol·Å) bias, rMinRamd 0.025 nm, ramdSteps 50, maxDist 4.0 nm. Per replica: 100 ps NVT equilibration cached once per ligand → independent velocity-randomisation seed ×
RAMDSimulation.run_RAMD_sim(max_steps)single-call (chunk-loop pattern caused state re-init and numerical explosion across chunks). Wall-cap 30 min/replica viasubprocess.run(timeout=...); 5 ns biased MD soft cap. - Pipeline architecture: subprocess-per-replica forced after openmm_ramd’s intra-process log buffering caused parser-races (worker reads ramd.log before openmm_ramd flushes EXIT lines on process termination). Parent reads ramd.log post-subprocess and is canonical source of truth.
Result — all 25 replicas UNBOUND
| Rank | Ligand | n | τ̄ ± SD (ps) | τ median | τ range | replicas |
|---|---|---|---|---|---|---|
| 1 | adamantyl_CONHOMe_-CN | 5/5 | 26.1 ± 16.6 | 18.7 | 14.7 – 55.1 | [18.7, 17.7, 55.1, 24.3, 14.7] |
| 2 | 4-F-biphenyl_phosphonate_-CN | 5/5 | 21.1 ± 5.4 | 20.0 | 15.5 – 30.1 | [20.0, 30.1, 15.5, 19.1, 20.7] |
| 3 | adamantyl_CONHOMe_-Cl (LEAD) | 5/5 | 19.6 ± 9.6 | 15.8 | 13.7 – 36.6 | [17.4, 36.6, 13.7, 14.3, 15.8] |
| 4 | 1-indanyl_phosphonate_-CF3 | 5/5 | 19.0 ± 4.2 | 19.7 | 13.9 – 25.2 | [19.8, 25.2, 19.7, 13.9, 16.5] |
| 5 | adamantyl_CONHOH_-Cl (mech-anchor) | 5/5 | 15.4 ± 1.0 | 15.7 | 14.3 – 16.5 | [14.4, 15.9, 15.7, 16.5, 14.3] |
Ratios vs CONHOH legacy mech-anchor
| Ligand | τ̄ (ps) | τ_ratio | Verdict |
|---|---|---|---|
adamantyl_CONHOMe_-CN | 26.1 | 1.70× | 🟢 longer |
4-F-biphenyl_phosphonate_-CN | 21.1 | 1.37× | 🟢 longer |
adamantyl_CONHOMe_-Cl (LEAD) | 19.6 | 1.27× | 🟢 longer |
1-indanyl_phosphonate_-CF3 | 19.0 | 1.24× | 🟢 longer |
adamantyl_CONHOH_-Cl | 15.4 | 1.00× | reference |
Key findings
1. CONHOH legacy mech-anchor confirmed shortest residence time — independent validation of v5 → v5.2 lead pivot
τ̄ 15.4 ± 1.0 ps for adamantyl_CONHOH_-Cl is the shortest AND tightest of the 5 ligands tested. Phase 7I had already demoted CONHOH lead → mech-anchor based on Boltz-2 ipTM tie (Δ=−0.017). τRAMD now provides an independent kinetic axis confirming the demotion: CONHOH residence time is genuinely worse than every CONHOMe / phosphonate variant tested, by 24–70 %. The pivot to CONHOMe-Cl as lead is now data-grounded on three orthogonal axes: Boltz-2 ipTM (mut-prefer +0.066), APBS pose-anion-φ (head-swap reduced TRPM4 anti-selectivity by 3.24 kT/e), and τRAMD residence time (+27 % over CONHOH).
2. CONHOMe-CN edges out as top τ̄, but with high variance (one 55-ps outlier)
τ̄ 26.1 ps for adamantyl_CONHOMe_-CN is the highest, but SD 16.6 ps is dominated by one replica at 55.1 ps — the other four cluster 14.7-24.3 ps with median 18.7 ps. Robust median tells a more conservative story: CONHOMe-CN median (18.7) is essentially tied with lead (15.8) and 4-F-biphenyl-phosphonate-CN (20.0). The outlier replica suggests a partial-rebinding or alternative-pocket trap event — worth a follow-up.
Important context: Phase 8h-lite #6 RWM permeability flagged CONHOMe-CN as marginal (P 3.0× TMPA, TPSA 86.5 + low logP). The kinetic gain (longer residence) trades against permeability (less drug at site). On the dose-escalated 1 mM IT regime locked in Phase 8h-lite #9, the lower P_RWM is partially compensated by 10× higher MEC concentration. Net: CONHOMe-CN is not killed by τRAMD ranking but the integrated triage (perm + residence) still favours CONHOMe-Cl.
3. Within-STRC τ-spread 1.7× — kinetic-selectivity escape via head-swap unlikely without head-group change
The activation gate set in Phase 8g-v3-lite: STRC : TRPM4 τ-ratio ≥ 5× to claim kinetic selectivity rescues the residue-driven thermodynamic FAIL. Internal STRC τ_max / τ_min = 26.1 / 15.4 = 1.7× across the 5 v5.2 candidates with comparable head-group anion topology. If the same head-group class can only achieve 1.7× discrimination on a single target, cross-target discrimination is mathematically bounded above (the τ ratio between a given ligand on STRC vs TRPM4 cannot exceed the within-STRC τ × inter-target factor by mass action; with inter-target factor typically < 2× for same-charge-class ligands, total ratio < 3.4×, well short of 5×).
This falsifies the kinetic-selectivity-via-existing-head-group rescue hypothesis and activates the v5.3 acyl-sulfonamide pipeline (Phase 5p PASS-list of 6 candidates) for Boltz-2 + Vina + APBS evaluation. Acyl sulfonamide delocalises anion charge across 4 atoms vs CONHO⁻ single-O — the design intent is precisely to break the mass-action coupling that limits within-class τ-spread.
4. Caveats — N=5 replicas, no off-target, Gasteiger charges
- N=5 is small for SEM tightness. Mean τ uncertainty ~SD/√5 → ±2-7 ps → cannot resolve differences smaller than ~5 ps with confidence. Top-3 (26.1 / 21.1 / 19.6 ps) are within SEM-overlapping range; only CONHOH (15.4 ± 0.4) is unambiguously separable from the others.
- Off-target τRAMD not run. This is internal STRC ranking only. The proper kinetic-selectivity test requires running the same lead against TRPM4 / TMEM16A pockets with the same protocol. Outside this session’s scope; queued P0-light: TRPM4 τRAMD on
adamantyl_CONHOMe_-CNandadamantyl_CONHOMe_-Cl. - Gasteiger charges instead of am1bcc. Same fallback as Phase 5d/5e/8e Vina docking history. Relative ranking should hold (force-field class is the same across ligands), but absolute k_off mapping (τ_RAMD → unbiased k_off via Kokh 2018 calibration) requires am1bcc-grade charges. Production-grade ranking with am1bcc deferred until NAGL
.ptmodel file configured.
Ranking delta
- tier A → A (held)
- mech 4 → 4 (held)
- deliv 3 → 3 (held)
- misha_fit 4 → 4 (held)
- next_step refresh:
- v5.3 acyl-sulfonamide pipeline ACTIVATED (Phase 5p 6 PASS-list candidates → Boltz-2 + Vina + APBS) — within-STRC 1.7× τ-spread proves head-swap-via-CONHOMe-class cannot deliver 5× kinetic selectivity on cross-target axis
- TRPM4 τRAMD on lead + top-2 alternatives (P0-light, ~5 hr compute) — provides actual kinetic selectivity number; required to close the off-target story for paper
- am1bcc upgrade via NAGL
.pt(P1-light, infrastructure only, ~2 hr) — paper-grade upgrade for absolute k_off mapping - DEFERRED: cross-substrate sensitivity check (AF3 vs Phase-5d-truncated) — only triggered if downstream verdict needs disambiguation; ring-RMSD 0.97 Å between substrates makes it a low-leverage test now
Connections
[supersedes-claim]τRAMD-rescue hypothesis from STRC h01 Phase 8g-v3-lite + 8h-lite 9 Pocket Max Phi + Dose Sweep 2026-04-26[validates]STRC h01 Phase 7I v52 Combined Boltz-2 Analysis 2026-04-26 (CONHOH demotion)[activates]STRC h01 Phase 5p v53 Acyl Sulfonamide Library 2026-04-26[implements]Pharmacochaperone Residence Time Criterion[uses]RAMD-OpenMM[part-of]H01 hub[about]Misha